Search

everythinglearnresearchcommunity

for

Search:↓

Clinical signs don't match inflammation levels in lichen planopilaris and frontal fibrosing alopecia.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

The best treatment for Frontal Fibrosing Alopecia and Lichen Planopilaris combines oral and topical medications to reduce symptoms and stop hair loss.

FAPD in children may not depend on androgens and should be treated with anti-inflammatory measures and minoxidil.

Upper eyelid hyperpigmentation can help diagnose facial lichen planus pigmentosus in patients with frontal fibrosing alopecia.

A woman's skin darkened after using dutasteride and pimecrolimus for hair loss, but improved when she stopped the medications and protected her skin from light.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

Sunscreen particles were not found in inflamed or fibrotic areas of skin in FFA patients, suggesting no direct link to the disease.

Early diagnosis and quick treatment improve life quality for FFA patients.

The document concludes that different types of permanent hair loss conditions are related and early treatment is key to preventing further damage.

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.

A woman's hair loss from graft versus host disease helps understand similar hair loss conditions.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatment strategies.

Protein profiling of forehead skin can help distinguish between frontal fibrosing alopecia and androgenetic alopecia.

LC-OCT is an effective new method for diagnosing classic lichen planopilaris.

Accurate diagnosis is crucial for effective treatment of similar hair loss conditions.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

Menopause can cause hair loss in women due to hormonal changes, affecting their well-being and quality of life.

New digital tools are improving the diagnosis and understanding of irreversible hair loss conditions.

Early diagnosis of pseudopelade of Brocq in men is crucial to prevent permanent hair loss.

The document concludes that "hot comb alopecia" is now called "central cicatricial centrifugal alopecia" and its causes are complex.

Postmenopausal women can experience hairline recession, affecting their quality of life, and more research is needed for treatments.

The workshop aimed to improve hair loss disorder diagnosis and understanding.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Title change to "Central Centrifugal Cicatricial Alopecia (CCCA)"; common in African American women; hair-grooming methods may contribute; no effective therapy found; trials needed.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.